Peptable

Comparison

KPV vs Selank

Also see:

KPVSelank

Function

While KPV is investigated as an anti-inflammatory and barrier-protective agent in skin and mucosal models, reducing pro-inflammatory cytokines and promoting tissue repair684, Selank is a peptide developed in Russia as an anxiolytic and nootropic; in animal models it reduces anxiety-like behavior and modulates immune parameters under stress39.

Mechanism

While KPV works as the C-terminal Lys-Pro-Val tripeptide fragment of α-MSH, which exerts potent anti-inflammatory effects largely via inhibition of NF-κB signaling and modulation of cytokine expression, with many actions independent of classical melanocortin receptor activation684, Selank is a synthetic heptapeptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, that combines a tuftsin fragment with a Pro-Gly-Pro motif and is reported to modulate GABAergic neurotransmission and cytokine balance while being resistant to proteolytic degradation39.

Receptor

KPV

No single primary receptor; the KPV motif can influence melanocortin receptor binding profiles (MC1R–MC5R), but many anti-inflammatory effects appear melanocortin-independent684

Selank

Not clearly established in the current dataset.

Organism or Origin

KPV

Endogenous tripeptide corresponding to positions 11–13 of human α-MSH8490

Selank

Synthetic analog of the IgG-derived tetrapeptide tuftsin39

Gene

KPV

POMC

Selank

Not assigned in the current dataset.

Summary

Both peptides fall into a similar broad context as Immune-modulating peptides, although the details of how they are used and discussed still diverge. Both are often discussed in Immunology and inflammation contexts, while KPV is more of a signal peptide and Selank is better described as a neuropeptide. Both appear to work through Signaling modulator, but the functional emphasis still separates, with KPV leaning toward Anti-inflammatory and Selank leaning toward Anxiolytic and sleep modulation. KPV has a more natural endogenous origin, while Selank is closer to synthetic analog background with KPV in Preclinical development and Selank approved for Research use only. Their sequence patterns also diverge, with KPV showing protein-mimetic sequence features and Selank showing proline-rich features.

Related articles

No related articles are linked to these peptides yet.